Intra-cellular therapies to host second quarter 2022 financial results conference call and webcast

New york, aug. 02, 2022 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. eastern time on tuesday, august 9, 2022, to provide a corporate update and discuss details of the company's financial results for the quarter ended june 30, 2022.
ITCI Ratings Summary
ITCI Quant Ranking